SCHEMBL7732757

SCHEMBL7732757

Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(OC(F)(F)F)c2ccc(F)c(F)c2)[C@@H](O)[C@H]1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 4/20 0.74
▸ WDR77 Q9BQA1 4/20 0.74
▸ AHCY P23526 8/20 0.52
▸ NADK O95544 1/20 0.48
▸ DPP4 P27487 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ SLC28A1 O00337 1/20 0.48
▸ MAP3K7 O43318 1/20 0.48
▸ SLC28A2 O43868 1/20 0.48
▸ GAPDH P04406 1/20 0.48
▸ ADORA3 P0DMS8 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ ADORA2A P29274 1/20 0.48
▸ ADORA2B P29275 1/20 0.48
▸ ADORA1 P30542 1/20 0.48
▸ STAT6 P42226 1/20 0.48
▸ PI4KA P42356 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ PI4K2B Q8TCG2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7732588 0.90 PRMT5 (0.59) PRMT5WDR77AHCYNADKDPP4
SCHEMBL21413928 0.85 PRMT5 (1.00) PRMT5WDR77AHCY
SCHEMBL18039043 0.85 PRMT5 (1.00) PRMT5WDR77AHCY
SCHEMBL18009839 0.85 PRMT5 (1.00) PRMT5WDR77AHCY
SCHEMBL7734952 0.80 PRMT5 (0.60) PRMT5WDR77AHCYNADKDPP4
SCHEMBL7735071 0.79 AHCY (0.58) PRMT5WDR77AHCYDPP4MEN1
SCHEMBL24478704 0.78 PRMT5 (0.84) PRMT5WDR77
SCHEMBL24625951 0.78 PRMT5 (0.84) PRMT5WDR77
SCHEMBL24626067 0.76 PRMT5 (0.73) PRMT5WDR77AHCY
SCHEMBL800351 0.76 PRMT5 (0.64) PRMT5WDR77AHCYDPP4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407076-B1 ANTIISCHEMIC, ANTILIPOLYTIC, ANTICONVULSANT AND HYPOTENSIVE AGENTS; CARDIOVASCULAR AND NERVOUS SYSTEM DISORDERS; ATHEROSCLEROSIS SMITHKLINE BEECHAM CORPORATION 2002-06-18 — — US claimed
Send feedback